NASDAQ:IPCI - IntelliPharmaCeutics Intl News Headlines

$0.22
0.00 (0.00 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
$0.2001
Now: $0.2150
$0.2199
50-Day Range
$0.2076
MA: $0.22
$0.2748
52-Week Range
$0.20
Now: $0.2150
$6.60
Volume114,246 shs
Average Volume1.02 million shs
Market Capitalization$4.71 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17

Headlines

IntelliPharmaCeutics Intl (NASDAQ IPCI) News Headlines

Source:
DateHeadline
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Second Quarter 2019 ResultsIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Second Quarter 2019 Results
www.finanznachrichten.de - July 11 at 10:04 AM
Intellipharmaceutics International Inc. Announces $10,000,000 Equity Financing CommitmentIntellipharmaceutics International Inc. Announces $10,000,000 Equity Financing Commitment
finance.yahoo.com - July 9 at 11:02 AM
Intellipharmaceutics International Inc.: Intellipharmaceutics to present at the 9th Annual LD Micro InvitationalIntellipharmaceutics International Inc.: Intellipharmaceutics to present at the 9th Annual LD Micro Invitational
www.finanznachrichten.de - May 29 at 10:48 AM
U.S. FDA Acknowledges Receipt of Intellipharmaceutics Resubmission of Oxycodone ER New Drug Application, Deems it a Complete Response, and Designates August 28, 2019 as Goal Date for ReviewU.S. FDA Acknowledges Receipt of Intellipharmaceutics' Resubmission of Oxycodone ER New Drug Application, Deems it a Complete Response, and Designates August 28, 2019 as Goal Date for Review
finance.yahoo.com - March 29 at 12:18 PM
Intellipharmaceutics Receives Nasdaq Listing Determination; To Begin Trading on the OTC Markets SystemIntellipharmaceutics Receives Nasdaq Listing Determination; To Begin Trading on the OTC Markets System
finance.yahoo.com - March 20 at 11:20 AM
Four Marijuana Stocks Green and Ready for the PickingFour Marijuana Stocks Green and Ready for the Picking
finance.yahoo.com - March 4 at 4:12 PM
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ERIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER
www.finanznachrichten.de - March 4 at 8:11 AM
Intellipharmaceutics Receives Extension from Nasdaq Hearings PanelIntellipharmaceutics Receives Extension from Nasdaq Hearings Panel
finance.yahoo.com - January 29 at 11:19 AM
Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based ProductsIntellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products
finance.yahoo.com - January 7 at 10:12 AM
NASDAQ Schedules Hearing to Consider Intellipharmaceutics (TM) Continued ListingNASDAQ Schedules Hearing to Consider Intellipharmaceutics' (TM) Continued Listing
www.benzinga.com - December 5 at 10:03 AM
NASDAQ Schedules Hearing to Consider Intellipharmaceutics’ (TM) Continued ListingNASDAQ Schedules Hearing to Consider Intellipharmaceutics’ (TM) Continued Listing
finance.yahoo.com - December 5 at 10:03 AM
The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma EarningsThe Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings
finance.yahoo.com - November 28 at 4:09 PM
Intellipharmaceutics Announces FDA Final Approval of Generic Effexor® XRIntellipharmaceutics Announces FDA Final Approval of Generic Effexor® XR
finance.yahoo.com - November 28 at 10:25 AM
Intellipharmaceutics Submits Investigational New Drug Application to the U.S. FDA for IPCI006 (oxycodone hydrochloride immediate release) Tablets Incorporating its Abuse Deterrent and Overdose Resistant TechnologyIntellipharmaceutics Submits Investigational New Drug Application to the U.S. FDA for IPCI006 (oxycodone hydrochloride immediate release) Tablets Incorporating its Abuse Deterrent and Overdose Resistant Technology
finance.yahoo.com - November 27 at 10:47 AM
Form 6-K Intellipharmaceutics For: Nov 21Form 6-K Intellipharmaceutics For: Nov 21
www.streetinsider.com - November 22 at 9:39 AM
Intellipharmaceutics Reports Exclusive Supply Agreement for its Abuse-Deterrent Oxycodone ER Product Candidate and Four Generic Drug Products in the PhilippinesIntellipharmaceutics Reports Exclusive Supply Agreement for its Abuse-Deterrent Oxycodone ER Product Candidate and Four Generic Drug Products in the Philippines
finance.yahoo.com - November 22 at 9:39 AM
Intellipharmaceutics International Inc.: Intellipharmaceutics Reports Exclusive Distribution Agreements in Malaysia and VietnamIntellipharmaceutics International Inc.: Intellipharmaceutics Reports Exclusive Distribution Agreements in Malaysia and Vietnam
www.finanznachrichten.de - November 21 at 9:38 AM
Intellipharmaceutics Reports Exclusive Distribution Agreements in Malaysia and VietnamIntellipharmaceutics Reports Exclusive Distribution Agreements in Malaysia and Vietnam
finance.yahoo.com - November 21 at 9:38 AM
Intellipharmaceutics Announces Resignation of Chief Financial OfficerIntellipharmaceutics Announces Resignation of Chief Financial Officer
finance.yahoo.com - November 6 at 9:46 AM
3 Healthcare Stocks to Watch in the 4th Quarter3 Healthcare Stocks to Watch in the 4th Quarter
www.baystreet.ca - October 26 at 10:09 AM
Intellipharmaceutics Regains Compliance with Nasdaq Minimum Shareholders Equity Listing RequirementsIntellipharmaceutics Regains Compliance with Nasdaq Minimum Shareholders' Equity Listing Requirements
finance.yahoo.com - October 26 at 10:09 AM
Form 6-K Intellipharmaceutics For: Oct 17Form 6-K Intellipharmaceutics For: Oct 17
www.streetinsider.com - October 19 at 4:10 PM
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Closing of US $14.3 Million Underwritten Public OfferingIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Closing of US $14.3 Million Underwritten Public Offering
www.finanznachrichten.de - October 17 at 9:37 AM
Intellipharmaceutics Announces Closing of US $14.3 Million Underwritten Public OfferingIntellipharmaceutics Announces Closing of US $14.3 Million Underwritten Public Offering
finance.yahoo.com - October 17 at 9:37 AM
Intellipharmaceutics Announces Third Quarter 2018 ResultsIntellipharmaceutics Announces Third Quarter 2018 Results
finance.yahoo.com - October 16 at 9:44 AM
Intellipharmaceutics (IPCI) Prices 17.39M Unit Upsized Offering at $0.75/UnitIntellipharmaceutics (IPCI) Prices 17.39M Unit Upsized Offering at $0.75/Unit
www.streetinsider.com - October 13 at 9:11 AM
Intellipharmaceutics Announces Pricing of $13 Million Upsized Underwritten Public OfferingIntellipharmaceutics Announces Pricing of $13 Million Upsized Underwritten Public Offering
finance.yahoo.com - October 12 at 9:28 AM
Intellipharmaceutics Announces Completion of the Clinical Component of Category 2 and 3 Human Abuse Liability Studies for Oxycodone ERIntellipharmaceutics Announces Completion of the Clinical Component of Category 2 and 3 Human Abuse Liability Studies for Oxycodone ER
finance.yahoo.com - October 11 at 9:24 AM
Intellipharmaceutics Regains Compliance with NASDAQ Minimum Bid Price Requirement; Also Receives Requested Extension from NASDAQ PanelIntellipharmaceutics Regains Compliance with NASDAQ Minimum Bid Price Requirement; Also Receives Requested Extension from NASDAQ Panel
finance.yahoo.com - October 1 at 9:42 AM
Form 6-K Intellipharmaceutics For: Sep 13Form 6-K Intellipharmaceutics For: Sep 13
www.streetinsider.com - September 14 at 9:46 AM
Intellipharmaceutics Announces One-for-10 Reverse Stock SplitIntellipharmaceutics Announces One-for-10 Reverse Stock Split
finance.yahoo.com - September 13 at 9:49 AM
Intellipharmaceutics International Inc.: Intellipharmaceutics Closes US$0.5 Million Convertible Debenture FinancingIntellipharmaceutics International Inc.: Intellipharmaceutics Closes US$0.5 Million Convertible Debenture Financing
www.finanznachrichten.de - September 12 at 9:25 AM
Form 6-K Intellipharmaceutics For: Sep 10Form 6-K Intellipharmaceutics For: Sep 10
www.streetinsider.com - September 11 at 4:03 PM
Intellipharmaceutics Closes US$0.5 Million Convertible Debenture FinancingIntellipharmaceutics Closes US$0.5 Million Convertible Debenture Financing
finance.yahoo.com - September 11 at 10:13 AM
Intellipharmaceutics Announces Second Quarter 2018 ResultsIntellipharmaceutics Announces Second Quarter 2018 Results
finance.yahoo.com - July 17 at 9:25 AM
Intellipharmaceutics: Fiscal 2Q Earnings SnapshotIntellipharmaceutics: Fiscal 2Q Earnings Snapshot
finance.yahoo.com - July 17 at 9:25 AM
Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from NASDAQIntellipharmaceutics Receives Anticipated Additional Staff Determination Letter from NASDAQ
finance.yahoo.com - June 9 at 9:27 AM
BRIEF-Intellipharmaceutics Received Notice From Nasdaq Hearings PanelBRIEF-Intellipharmaceutics Received Notice From Nasdaq Hearings Panel
www.reuters.com - May 23 at 9:28 AM
Nasdaq Hearings Panel Grants Intellipharmaceutics Request for Continued ListingNasdaq Hearings Panel Grants Intellipharmaceutics' Request for Continued Listing
finance.yahoo.com - May 22 at 4:09 PM
Intellipharmaceutics Reports Director Election ResultsIntellipharmaceutics Reports Director Election Results
finance.yahoo.com - May 16 at 10:25 AM
Intellipharmaceutics Bounces on New Oxycodone ER StudiesIntellipharmaceutics Bounces on New Oxycodone ER Studies
www.baystreet.ca - May 8 at 4:05 PM
Form 6-K Intellipharmaceutics For: May 08Form 6-K Intellipharmaceutics For: May 08
www.streetinsider.com - May 8 at 9:50 AM
Intellipharmaceutics Announces Start of Intranasal Human Abuse Liability Studies for Oxycodone ERIntellipharmaceutics Announces Start of Intranasal Human Abuse Liability Studies for Oxycodone ER
finance.yahoo.com - May 8 at 9:50 AM
Wired News – Asterias Biotherapeutics: Clinical Grade Lot Released to Support Dosing of Subjects in First Clinical Study of AST-VAC2 in Non-Small Cell Lung CancerWired News – Asterias Biotherapeutics: Clinical Grade Lot Released to Support Dosing of Subjects in First Clinical Study of AST-VAC2 in Non-Small Cell Lung Cancer
finance.yahoo.com - April 27 at 10:37 AM
Intellipharmaceutics Files Appeal to Nasdaq Delisting DeterminationIntellipharmaceutics Files Appeal to Nasdaq Delisting Determination
finance.yahoo.com - April 27 at 10:37 AM
Intellipharmaceutics Receives Delisting Determination from NASDAQ Staff; Company to Request HearingIntellipharmaceutics Receives Delisting Determination from NASDAQ Staff; Company to Request Hearing
finance.yahoo.com - April 24 at 9:56 AM
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2018 ResultsIntellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2018 Results
www.finanznachrichten.de - April 17 at 10:03 AM
Intellipharmaceutics Announces First Quarter 2018 ResultsIntellipharmaceutics Announces First Quarter 2018 Results
finance.yahoo.com - April 17 at 10:02 AM
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Closing of US$1.8 Million FinancingIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Closing of US$1.8 Million Financing
www.finanznachrichten.de - March 22 at 9:50 AM
Intellipharmaceutics Announces Closing of US$1.8 Million FinancingIntellipharmaceutics Announces Closing of US$1.8 Million Financing
finance.yahoo.com - March 22 at 9:50 AM
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel